Published Technical Documents

Standards, guidance and application literature from the bodies and manufacturers that publish it. Every entry links to the document page itself and quotes the sentence that says what it covers.

Filter documents

Showing 253 - 264 of 1411 published documents. 1411 carry a quoted source excerpt, from 16 publishers.

FDA 510(k) index record K202101. Device: GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Test (ACT-LR), directCHECK ACT+ Whole Blood Control, Level 1 and Level 2, directCHECK ACT-LR Whole Blood Control, Level 1 and Level 2. Applicant as listed: Accriva Diagnostics, Inc.. Decision date: 2021-12-29.

Source: api.fda.gov · Retrieved 2026-10-19

Key takeaways

Every item here is a technical document its publisher made public: a standards-body scope page, a regulator guidance document, or a manufacturer application note or journal article. The entry links to that page and quotes the sentence describing what the document covers. It is not a record of work IVDmap has done.

Target audienceImplementation teams, labs, procurement managers

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-01

Updated

2026-10-09

Disclaimer

professional use

Every document below is published by the body named on it, and this page links to that page. Nothing here is a record of work IVDmap has done.